Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Revision of Prior Period, Accounting Standards Update, Adjustment	[1]	Common Stock	Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period (in shares) at Dec. 31, 2022				17,598,123
Balance at beginning of period at Dec. 31, 2022	$ 230,268	$ (1,198)		$ 17,598	$ 167,537	$ 111,573	$ (66,440)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive loss	6,216						6,216
Dividends on common shares	(1,933)					(1,933)
Issuance of restricted stock, net of forfeitures (in shares)				1,546
Issuance of restricted stock, net of forfeitures	0			$ 2	(2)
Tax withholding related to vesting of restricted stock (in shares)				(5,790)
Tax withholding related to vesting of restricted stock	(73)			$ (6)	(67)
Stock-based compensation expense	454				454
Net income	5,043					5,043
Balance at end of period (in shares) at Mar. 31, 2023				17,593,879
Balance at end of period at Mar. 31, 2023	$ 238,777			$ 17,594	167,922	113,485	(60,224)
Balance at beginning of period (in shares) at Dec. 31, 2023	17,564,182			17,564,182
Balance at beginning of period at Dec. 31, 2023	$ 254,935			$ 17,564	168,614	124,400	(55,643)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive loss	1,289						1,289
Dividends on common shares	(1,975)					(1,975)
Issuance of restricted stock, net of forfeitures (in shares)				(594)
Issuance of restricted stock, net of forfeitures	0
Tax withholding related to vesting of restricted stock (in shares)				(4,977)
Tax withholding related to vesting of restricted stock	(66)			$ (5)	(61)
Stock-based compensation expense	398				398
Net income	$ 5,333					5,333
Balance at end of period (in shares) at Mar. 31, 2024	17,558,611			17,558,611
Balance at end of period at Mar. 31, 2024	$ 259,914			$ 17,559	$ 168,951	$ 127,758	$ (54,354)

[1]  (1) Represents the impact of the adoption of Accounting Standards Update ("ASU") No. 2016-13: CECL